These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34582671)

  • 61. Burden of lymphatic disease predicts efficacy of adjuvant radiation and chemotherapy in FIGO 2018 stage IIICp cervical cancer.
    Bogani G; Vinti D; Murgia F; Chiappa V; Leone Roberti Maggiore U; Martinelli F; Ditto A; Raspagliesi F
    Int J Gynecol Cancer; 2019 Nov; 29(9):1355-1360. PubMed ID: 31422352
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Adenocarcinoma histology is a poor prognostic factor in locally advanced cervical cancer.
    Jonska-Gmyrek J; Gmyrek L; Zolciak-Siwinska A; Kowalska M; Kotowicz B
    Curr Med Res Opin; 2019 Apr; 35(4):595-601. PubMed ID: 30019594
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prediction scoring system based on clinicohematologic parameters for cervical cancer patients undergoing chemoradiation.
    Kim YJ; Kim YS; Shin JW; Osong B; Lee SH
    Int J Gynecol Cancer; 2020 Nov; 30(11):1689-1696. PubMed ID: 32546642
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Ten Years’ Survival in Patients with Cervical Cancer and Related Factors in West Azerbaijan Province: Using of Cox Proportion Hazard Model.
    Khalkhali HR; Gharaaghaji R; Valizadeh R; Kousehlou Z; Ayatollahi H
    Asian Pac J Cancer Prev; 2019 May; 20(5):1345-1351. PubMed ID: 31127888
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Influence of histologic type and age on survival rates for invasive cervical carcinoma in Taiwan.
    Chen RJ; Lin YH; Chen CA; Huang SC; Chow SN; Hsieh CY
    Gynecol Oncol; 1999 May; 73(2):184-90. PubMed ID: 10329032
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A new marker based on risk stratification of human papillomavirus DNA and tumor size to predict survival of locally advanced cervical cancer.
    Huang Y; He Q; Xu K; Zhou J; Yin J; Li F; Feng M; Lang J
    Int J Gynecol Cancer; 2019 Mar; 29(3):459-465. PubMed ID: 30733276
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Histopathologic score predicts recurrence free survival after radical surgery in patients with stage IA2-IB1-2 cervical carcinoma.
    Grisaru DA; Covens A; Franssen E; Chapman W; Shaw P; Colgan T; Murphy J; DePetrillo D; Lickrish G; Laframboise S; Rosen B
    Cancer; 2003 Apr; 97(8):1904-8. PubMed ID: 12673716
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinicopathological Features and Survival of Adolescent and Young Adults with Cervical Cancer.
    Pan S; Jiang W; Xie S; Zhu H; Zhu X
    Cancer Control; 2021; 28():10732748211051558. PubMed ID: 34648722
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparing survival outcomes for cervical cancer based on the 2014 and 2018 International Federation of Gynecology and Obstetrics staging systems.
    Shin W; Ham TY; Park YR; Lim MC; Won YJ
    Sci Rep; 2021 Mar; 11(1):6988. PubMed ID: 33772044
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Impact of nodal status and treatment strategy on overall survival in advanced stage cervical cancer.
    Papathemelis T; Knobloch S; Gerken M; Scharl A; Anapolski M; Ignatov A; Inwald EC; Ortmann O; Scharl S; Klinkhammer-Schalke M
    J Cancer Res Clin Oncol; 2019 May; 145(5):1369-1376. PubMed ID: 30887156
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Ovarian, uterine, and cervical cancer patients with distant metastases at diagnosis: most common locations and outcomes.
    Gardner AB; Charo LM; Mann AK; Kapp DS; Eskander RN; Chan JK
    Clin Exp Metastasis; 2020 Feb; 37(1):107-113. PubMed ID: 31758289
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Evaluation of the efficacy of prophylactic extended field irradiation in the concomitant chemoradiotherapy treatment of locally advanced cervical cancer, stage IIIB in the 2018 FIGO classification.
    Meng Q; Liu X; Wang W; Hou X; Lian X; Sun S; Yan J; Liu Z; Miao Z; Hu K; Zhang F
    Radiat Oncol; 2019 Dec; 14(1):228. PubMed ID: 31842919
    [TBL] [Abstract][Full Text] [Related]  

  • 73. microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer.
    Park S; Kim J; Eom K; Oh S; Kim S; Kim G; Ahn S; Park KH; Chung D; Lee H
    BMC Cancer; 2019 May; 19(1):419. PubMed ID: 31060525
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Validation of the 2018 FIGO Staging System for Predicting the Prognosis of Patients With Stage IIIC Cervical Cancer.
    Long X; He M; Yang L; Zou D; Wang D; Chen Y; Zhou Q
    Clin Med Insights Oncol; 2023; 17():11795549221146652. PubMed ID: 36726607
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cervical cancer survival for patients referred to a tertiary care center in Kentucky.
    Seamon LG; Tarrant RL; Fleming ST; Vanderpool RC; Pachtman S; Podzielinski I; Branscum AJ; Feddock JM; Randall ME; Desimone CP
    Gynecol Oncol; 2011 Dec; 123(3):565-70. PubMed ID: 21963092
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Radical hysterectomy with adjuvant radiotherapy versus definitive radiotherapy alone for FIGO stage IIB cervical cancer.
    Mabuchi S; Okazawa M; Isohashi F; Matsuo K; Ohta Y; Suzuki O; Yoshioka Y; Enomoto T; Kamiura S; Kimura T
    Gynecol Oncol; 2011 Nov; 123(2):241-7. PubMed ID: 21820708
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Propensity Score Analysis of Radical Hysterectomy Versus Definitive Chemoradiation for FIGO Stage IIB Cervical Cancer.
    Tomita N; Mizuno M; Makita C; Kondo S; Mori M; Sakata J; Tsubouchi H; Hirata K; Tachibana H; Kodaira T
    Int J Gynecol Cancer; 2018 Oct; 28(8):1576-1583. PubMed ID: 30095702
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Stage IIA1 versus stage IIA2 cervical cancer: does the new staging criteria predict survival?
    Garg G; Shah JP; Toy EP; Christensen C; Deppe G; Asaad R; Morris RT
    Int J Gynecol Cancer; 2011 May; 21(4):711-6. PubMed ID: 21412165
    [TBL] [Abstract][Full Text] [Related]  

  • 79. FIGO 2018 stage IB endocervical adenocarcinomas: an international study of outcomes informed by prognostic biomarkers.
    Stolnicu S; Boros M; Hoang L; Almadani N; de Brot L; Baiocchi G; Bonvolim G; Parra-Herran C; Lerias S; Felix A; Roma A; Pesci A; Oliva E; Park K; Soslow RA; Abu-Rustum NR
    Int J Gynecol Cancer; 2021 Feb; 31(2):177-184. PubMed ID: 33177150
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Different prognosis of stage IIIB cervical cancer patients with lower third of vaginal invasion and those without.
    Fang C; Zhang P; Yu A; Yang Y; Zhang J
    Gynecol Oncol; 2021 Jul; 162(1):50-55. PubMed ID: 33858676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.